We are live on ! Find out more
SRTS icon

Sensus Healthcare

21 hedge funds and large institutions have $6.19M invested in Sensus Healthcare in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

24% more funds holding

Funds holding: 1721 (+4)

0.3% more ownership

Funds ownership: 10.31%10.6% (+0.3%)

39% less capital invested

Capital invested by funds: $10.2M → $6.19M (-$4.01M)

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
5
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change

SRTS Hedge Fund Activity: Q4 2019 in Review

21 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q4 2019, worth a combined $6.19M — down 39% from $10.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new SRTS positions and 2 closed out — a net gain of 4 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Truist Financial, opening a new position worth an estimated $99.6K. The largest seller was Perkins Capital Management, cutting an estimated $329K.

  • 21 institutional investors held Sensus Healthcare (SRTS) as of Q4 2019, up from 17 in Q3 2019.
  • Funds reported $6.19M of Sensus Healthcare stock for Q4 2019, down 39% quarter-over-quarter.
  • 6 funds opened new Sensus Healthcare positions in Q4 2019 and 2 closed out, a net change of +4 holders.
  • The largest Sensus Healthcare buyer in Q4 2019 was Truist Financial, an estimated $99.6K added.
  • The largest Sensus Healthcare seller in Q4 2019 was Perkins Capital Management, an estimated $329K sold.

Based on aggregated 13F filings for Q4 2019.